← Back to headlines
Truist Securities Downgrades Harmony Biosciences Holdings, Inc. (HRMY) to Hold After Patent Trial Developments
Truist Securities has downgraded Harmony Biosciences Holdings, Inc. (HRMY) to a 'Hold' rating following recent developments in a patent trial.
26 Feb, 13:57 — 26 Feb, 13:57
Sources
Showing 1 of 1 sources
